GPP
DTIL icon

Great Point Partners’s Precision BioSciences DTIL Stock Holding History

Great Point Partners’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-248,991
Closed -$3.93M – 46
2023
Q2 		$3.93M Sell
248,991
-21,002
-8% -$480K 0.77% 33
2023
Q1 		$6.1M Buy
269,993
+143,283
+113% +$4.72M 1.2% 25
2022
Q4 		$4.52M Buy
126,710
+36,350
+40% +$1.44M 0.89% 36
2022
Q3 		$3.52M Sell
90,360
-101,487
-53% -$4.82M 0.85% 31
2022
Q2 		$9.21M Buy
+191,847
New +$11.3M 2.21% 19

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Great Point Partners's DTIL Position: Q3 2023 in Review

Great Point Partners sold out of Precision BioSciences (DTIL) in Q3 2023, closing a stake of 248,991 shares — an estimated $3.93M sold.

Great Point Partners first reported a position in DTIL in Q2 2022 and held it in 5 quarters. The position peaked at $9.21M in Q2 2022. 76 funds tracked by Wall St. Rank hold DTIL as of Q3 2023.

  • Great Point Partners reported no remaining Precision BioSciences position as of Q3 2023 after selling out during the quarter.
  • Great Point Partners sold 248,991 Precision BioSciences shares in Q3 2023, an estimated $3.93M.
  • Great Point Partners first reported a position in Precision BioSciences in Q2 2022 and held it in 5 quarters.
  • Great Point Partners's Precision BioSciences position peaked at $9.21M in Q2 2022.
  • 76 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2023.

Based on Great Point Partners's 13F filing for Q3 2023, filed 14 Nov 2023.